2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Retroperitoneal Fibrosis: new trials by email Literature Review of Retroperitoneal Fibrosis trials Research Report on Retroperitoneal Fibrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of IgG4-Related Disease With Revlimid and Rituximab Rituximab, Lenalidomide - Immunoglobulin G Subclass 4 Related Disease, IgG4-related Disease | Phase 1 | Completed | Mayo Clinic | 6 | 2016-04-01 | 2019-07-08 |
| Rituximab in IgG4-RD: A Phase 1-2 Trial Rituximab - Retroperitoneal Fibrosis, Autoimmune Pancreatitis | Phase 1 / Phase 2 | Completed | Massachusetts General Hospital | 30 | 2012-04-01 | 2017-07-02 |
Autoimmune Pancreatitis (2) · Immunoglobulin G4-Related Disease (1) · Lymphadenopathy (1) · Meningitis (1) · Orbital Pseudotumor (1) · Sialadenitis (1)
Autoimmune Diseases (2) · Chronic Disease (2) · Digestive System Diseases (2) · Disease Attributes (2) · Fibrosis (2) · Immune System Diseases (2) · Pancreatic Diseases (2) · Pancreatitis (2) · Pancreatitis, Chronic (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Eye Diseases (1) · Hemic and Lymphatic Diseases (1) · Lymphatic Diseases (1) · Mouth Diseases (1)
Rituximab (2) · Lenalidomide (1)
Massachusetts General Hospital (1) · Mayo Clinic (1)
United States (1)
Arezou Khosroshahi, MD (1) · John H Stone, MD, MPH (1) · Mark D Topazian, MD (1)